The Center for Innovation & Value Research (the Center), a non-profit research organization committed to advancing the science, practice, and use of value assessment in healthcare announced the addition of five new members to its 2026 Board of Directors: Elizabeth Cope, PhD, MPH (Chief Programs & Science Officer, AcademyHealth), Amy Duhig, PHD (Senior Director, New Product Planning, Value and Evidence Generation, Takeda Pharmaceuticals), Kristi Mitchell, MPH (Founder and Principal, Atlas Clarity, LLC), Russ Montgomery, PhD (Head of Value Assessment Strategy and Policy, GSK), and Cristie Upshaw Travis, MSHHA (Senior Advisor, HealthCareTN).
They will start their three-year term of service in January 2026.
The new appointments to the Board will join the following 2026 Board members: Scott Brunner (Treasurer) (Deputy Secretary of Hospitals and Facilities, Kansas Department for Aging and Disability Services), Harold Carter, PharmD (Senior Vice President, Market Development & Pharma Contracting Vice President, Strategy & Contracting, Express Scripts), Mark Cziraky, PharmD, CLS (Past-Chairperson) (President, Carelon Research), Lisa Bo Feng, DrPH (Chairperson Elect) (Senior Director, Health of Policy, Alexion, AstraZeneca Rare Disease), Nelly Ganesan, MPH (Head of Strategy and Partnerships, Rock Health), Darcel Jackson, CPXP, LSSGB (Patient/Caregiver Advocate, Manager, Patient Centered Care, Children’s National Hospital), Stacy Lloyd, MPH (Chairperson) (Senior Director, Strategic Value & Insights, Xealth), Adam Thompson, MPH (Managing Director, Plain Speak Consulting, Inc.) .